Long-term patient survival: Strategies to improve overall health

American Journal of Kidney Diseases

Volumn 47, Issue 4 SUPPL. 2, 2006, Pages

  Adams, Patricia L ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b North Carolina Baptist Hospital   (United States)

Author keywords

Bone disease; Cardiovascular disease (CVD); Immunosuppression; Infection; Kidney transplantation; Long term care; Malignancy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GANCICLOVIR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEGLITINIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SULFONYLUREA; TSUKUBAENOLIDE; VALGANCICLOVIR;

CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DYSLIPIDEMIA; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; METABOLIC SYNDROME X; MORTALITY; RASH; REVIEW; RISK FACTOR; SURVIVAL TIME; URINARY TRACT INFECTION; VIRUS INFECTION;

EID: 33645284694     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.12.043     Document Type: Article

References (116)

1. US Renal Data System USRDS 2004 Annual Data Report 2004 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
2. American Society of Transplantation B.L. Kasiske, M.A. Vazquez, W.E. Harmon Recommendations for the outpatient surveillance of renal transplant recipients J Am Soc Nephrol 11 suppl 15 2000 S1 S86
3. United Network for Organ Sharing UNOS Organ Procurement and Transplant Network (OPTN) data as of June 1, 2005 2005 Available at: www.optn.org. Accessed June 1
4. H.U. Meier-Kriesche, R. Baliga, B. Kaplan Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation Transplantation 75 2003 1291 1295
5. C. Rigatto Clinical epidemiology of cardiac disease in renal transplant recipients Semin Dial 16 2003 106 110
6. B. Kasiske, F.G. Cosio, J. Beto Clinical practice guidelines for managing dyslipidemias in kidney transplant patients A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative Am J Transplant 4 2004 13 53
7. K.L. Lentine, D.C. Brennan, M.A. Schnitzler Incidence and predictors of myocardial infarction after kidney transplantation J Am Soc Nephrol 16 2005 496 506
8. H.U. Meier-Kriesche, J.D. Schold, T.R. Srinivas, A. Reed, B. Kaplan Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease Am J Transplant 4 2004 1662 1668
9. American Heart Association Heart Disease and Stroke Statistics 2005 Update 2005 American Heart Association Dallas, TX
10. C.M. Giachelli Vascular calcification mechanisms J Am Soc Nephrol 15 2004 2959 2964
11. D.V. Barreto, F.C. Barreto, A.B. Carvalho Coronary calcification in hemodialysis patients The contribution of traditional and uremia-related risk factors Kidney Int 67 2005 1576 1582
12. P.S. Parfrey The clinical epidemiology of cardiovascular disease in chronic kidney disease Semin Dial 16 2003 83 84
13. J.M. Boots, M.H. Christiaans, J.P. van Hooff Effect of immunosuppressive agents on long-term survival of renal transplant recipients Focus on the cardiovascular risk Drugs 64 2004 2047 2073
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report 2005 Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm. Accessed August 1
15. W. Grotz, S. Siebig, M. Olschewski, C.W. Strey, K. Peter Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation Transplantation 77 2004 1848 1853
16. B.L. Kasiske, S. Anjum, R. Shah Hypertension after kidney transplantation Am J Kidney Dis 43 2004 1071 1081
17. F. Vincenti, S.C. Jensik, R.S. Filo, J. Miller, J. Pirsch A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation Evidence for improved allograft survival at five years Transplantation 73 2002 775 782
18. R. Margreiter Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation A randomised multicentre study Lancet 359 2002 741 746
19. M.A. Artz, J.M. Boots, G. Ligtenberg Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile Am J Transplant 4 2004 937 945
20. B.K. Kramer, C. Zulke, M.C. Kammerl Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation Am J Transplant 3 2003 982 987
21. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S1 S290
22. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 28 suppl 1 2005 S37 S42
23. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients Am J Kidney Dis 45 suppl 3 2005 S16 S153
24. K. Midtvedt, A. Hartmann, A. Foss Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril Transplantation 72 2001 1787 1792
25. M. Lorenz, E. Billensteiner, M. Bodingbauer, R. Oberbauer, W.H. Horl, M. Haas The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function Am J Kidney Dis 43 2004 1065 1070
26. D. Montanaro, M. Gropuzzo, P. Tulissi Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients Transplant Proc 37 2005 991 993
27. C.A. Flores, L.G. Ardiles, C.A. Aros Valsartan-induced hematocrit changes in renal transplant patients Transplant Proc 37 2005 1586 1588
28. G.R. Hetzel, J. Plum, A. Fussholler, A. Voiculescu, W. Grunberg, B. Grabensee Effects of candesartan on glomerular hemodynamics and permselectivity in patients with favorable renal allograft function Transplantation 79 2005 710 715
29. N.C. Premasathian, R. Muehrer, P.C. Brazy, J.D. Pirsch, B.N. Becker Blood pressure control in kidney transplantation Therapeutic implications J Hum Hypertens 18 2004 871 877
30. R.N. Formica, A.L. Friedman, M.I. Lorber, M.J. Bia Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period Transplant Proc 36 2004 2675 2678
31. B.L. Kasiske, J.J. Snyder, D. Gilbertson, A.J. Matas Diabetes mellitus after kidney transplantation in the United States Am J Transplant 3 2003 178 185
32. R.S. Gaston, G. Basadonna, F.G. Cosio Transplantation in the diabetic patient with advanced chronic kidney disease A task force report Am J Kidney Dis 44 2004 529 542
33. V.M. Montori, A. Basu, P.J. Erwin, J.A. Velosa, S.E. Gabriel, Y.C. Kudva Posttransplantation diabetes A systematic review of the literature Diabetes Care 25 2002 583 592
34. M.O. Salifu, F. Tedla, P.V. Murty, S. Aytug, S.I. McFarlane Challenges in the diagnosis and management of new-onset diabetes after transplantation Curr Diabetes Rep 5 2005 194 199
35. J.P. van Hooff, M.H. Christiaans, E.M. van Duijnhoven Tacrolimus and posttransplant diabetes mellitus in renal transplantation Transplantation 79 2005 1465 1469
36. P.F. Mora Post-transplantation diabetes mellitus Am J Med Sci 329 2005 86 94
37. K. Midtvedt, J. Hjelmesaeth, A. Hartmann Insulin resistance after renal transplantation The effect of steroid dose reduction and withdrawal J Am Soc Nephrol 15 2004 3233 3239
38. F.G. Cosio, Y. Kudva, M. van der Velde New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation Kidney Int 67 2005 2415 2421
39. M.R. First, D.A. Gerber, S. Hariharan, D.B. Kaufman, R. Shapiro Posttransplant diabetes mellitus in kidney allograft recipients Incidence, risk factors, and management Transplantation 73 2002 379 386
40. American Diabetes Association Standards of medical care in diabetes Diabetes Care 28 suppl 1 2005 S4 S36
41. O. Heisel, R. Heisel, R. Balshaw, P. Keown New onset diabetes mellitus in patients receiving calcineurin inhibitors A systematic review and meta-analysis Am J Transplant 4 2004 583 595
42. S. Gourishankar, G.S. Jhangri, M. Tonelli, L.H. Wales, S.M. Cockfield Development of diabetes mellitus following kidney transplantation A Canadian experience Am J Transplant 4 2004 1876 1882
43. C.B. Drachenberg, D.K. Klassen, M.R. Weir Islet cell damage associated with tacrolimus and cyclosporine Morphological features in pancreas allograft biopsies and clinical correlation Transplantation 68 1999 396 402
44. E.M. van Duijnhoven, M.H. Christiaans, J.M. Boots, F.H. Nieman, B.H. Wolffenbuttel, J.P. van Hooff Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression J Am Soc Nephrol 13 2002 213 220
45. J.M. Boots, E.M. van Duijnhoven, M.H. Christiaans, B.H. Wolffenbuttel, J.P. van Hooff Glucose metabolism in renal transplant recipients on tacrolimus The effect of steroid withdrawal and tacrolimus trough level reduction J Am Soc Nephrol 13 2002 221 227
46. J. Davidson, A. Wilkinson, J. Dantal New-onset diabetes after transplantation 2003 International consensus guidelines Transplantation 75 suppl 10 2003 S3 S24 Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003
47. G.V. Prasad, S.J. Kim, M. Huang Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) Am J Transplant 4 2004 1897 1903
48. M. Kurella, J.C. Lo, G.M. Chertow Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 16 2005 2134 2140
49. A.P. de Vries, S.J. Bakker, W.J. van Son Metabolic syndrome is associated with impaired long-term renal allograft function; Not all component criteria contribute equally Am J Transplant 4 2004 1675 1683
50. H.U. Meier-Kriesche, J.A. Arndorfer, B. Kaplan The impact of body mass index on renal transplant outcomes A significant independent risk factor for graft failure and patient death Transplantation 73 2002 70 74
51. C.R. Parikh, P. Klem, C. Wong, R. Yalavarthy, L. Chan Obesity as an independent predictor of posttransplant diabetes mellitus Transplant Proc 35 2003 2922 2926
52. A.N. Friedman, D.C. Miskulin, I.H. Rosenberg, A.S. Levey Demographics and trends in overweight and obesity in patients at time of kidney transplantation Am J Kidney Dis 41 2003 480 487
53. R.M. Jindal, E.T. Zawada Obesity and kidney transplantation Am J Kidney Dis 43 2004 943 952
54. H. Holdaas, B. Fellstrom, A.G. Jardine Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation Nephrol Dial Transplant 20 2005 974 980
55. A.G. Jardine, H. Holdaas, B. Fellstrom ALERT Study Investigators Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients Post-hoc subgroup analyses of the ALERT Study Am J Transplant 4 2004 988 995
56. R. Mendez, T. Gonwa, H.C. Yang, S. Weinstein, S. Jensik, S. Steinberg A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation Results at 1 year Transplantation 80 2005 303 309
57. J.A. Kobashigawa Statins in solid organ transplantation Is there an immunosuppressive effect? Am J Transplant 4 2004 1013 1018
58. M.A. Albert, E. Danielson, N. Rifai, P.M. Ridker Effect of statin therapy on C-reactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study JAMA 286 2001 64 70
59. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, classification, and stratification Am J Kidney Dis 39 suppl 2 2002 S1 S266
60. T.C. Mix, W. Kazmi, S. Khan Anemia A continuing problem following kidney transplantation Am J Transplant 3 2003 1426 1433
61. A. Djamali, Y.T. Becker, W.D. Simmons, C.A. Johnson, N. Premasathian, B.N. Becker Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients Transplantation 76 2003 816 820
62. Y. Vanrenterghem, C. Ponticelli, J.M. Morales Prevalence and management of anemia in renal transplant recipients A European survey Am J Transplant 3 2003 835 845
63. European Best Practice Guidelines for Renal Transplantation. Section IV: Long-term management of the transplant recipient. IV.9.1. Haematological complications. Anaemia Nephrol Dial Transplant 17 2002 48 49
64. European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 19 suppl 2 2004 ii6
65. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease Update 2000 Am J Kidney Dis 37 suppl 1 2001 S182 S238
66. J.A. Fishman, R.H. Rubin Infection in organ-transplant recipients N Engl J Med 338 1998 1741 1751
67. C.N. Kotton, E.T. Ryan, J.A. Fishman Prevention of infection in adult travelers after solid organ transplantation Am J Transplant 5 2005 8 14
68. A. Bruchfeld, H. Wilczek, C.G. Elinder Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation Transplantation 78 2004 745 750
69. I.M. Mahmoud, A.F. Elhabashi, E. Elsawy, A.A. El-Husseini, G.E. Sheha, M.A. Sobh The impact of hepatitis C virus viremia on renal graft and patient survival A 9-year prospective study Am J Kidney Dis 43 2004 131 139
70. F. Fabrizi, P. Martin, V. Dixit, S. Bunnapradist, G. Dulai Hepatitis C virus antibody status and survival after renal transplantation Meta-analysis of observational studies Am J Transplant 5 2005 1452 1461
71. C. Triantos, D. Samonakis, R. Stigliano, U. Thalheimer, D. Patch, A. Burroughs Liver transplantation and hepatitis C virus Systematic review of antiviral therapy Transplantation 79 2005 261 268
72. R.B. Mannon Polyomavirus nephropathy What have we learned? Transplantation 77 2004 1313 1318
73. H.H. Hirsch, D.C. Brennan, C.B. Drachenberg Polyomavirus-associated nephropathy in renal transplantation Interdisciplinary analyses and recommendations Transplantation 79 2005 1277 1286
74. B. Celik, R. Shapiro, A. Vats, P.S. Randhawa Polyomavirus allograft nephropathy Sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression Am J Transplant 3 2003 1378 1382
75. D.C. Brennan, I. Agha, D.L. Bohl Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction Am J Transplant 5 2005 582 594
76. P.V. Kadambi, M.A. Josephson, J. Williams Treatment of refractory BK virus-associated nephropathy with cidofovir Am J Transplant 3 2003 186 191
77. R.K. Wali, C. Drachenberg, H.H. Hirsch BK virus-associated nephropathy in renal allograft recipients Rescue therapy by sirolimus-based immunosuppression Transplantation 78 2004 1069 1073
78. A.T. Rowshani, F.J. Bemelman, E.M. van Leeuwen, R.A. van Lier, I.J. ten Berge Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients Transplantation 79 2005 381 386
79. J. Ahmed, C. Velarde, M. Ramos Outcome of low-dose ganciclovir for cytomegalovirus disease prophylaxis in renal-transplant recipients Transplantation 78 2004 1689 1692
80. C. Paya, A. Humar, E. Dominguez Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 4 2004 611 620
81. K.C. Abbott, S.J. Swanson, E.R. Richter Late urinary tract infection after renal transplantation in the United States Am J Kidney Dis 44 2004 353 362
82. D. Jeyaratnam, A.M. Robson, J.M. Hextall, W. Wong, E. MacMahon Concurrent verrucous and varicelliform rashes following renal transplantation Am J Transplant 5 2005 1777 1780
83. E. Mahe, E. Morelon, S. Lechaton Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy Transplantation 79 2005 476 482
84. M.S. Kumar, D.R. Sierka, A.M. Damask Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients Kidney Int 67 2005 1622 1629
85. S. Feng, J.F. Buell, R.S. Chari, J.M. DiMaio, D.W. Hanto Tumors and transplantation The 2003 Third Annual ASTS State-of-the-Art Winter Symposium Am J Transplant 3 2003 1481 1487
86. B.L. Kasiske, J.J. Snyder, D.T. Gilbertson, C. Wang Cancer after kidney transplantation in the United States Am J Transplant 4 2004 905 913
87. E. Mahe, E. Morelon, J. Fermanian Renal-transplant recipients and sun protection Transplantation 78 2004 741 744
88. J.C. Donovan, C.F. Rosen, J.C. Shaw Evaluation of sun-protective practices of organ transplant recipients Am J Transplant 4 2004 1852 1858
89. I.M. Ghobrial, T.M. Habermann, W.R. Macon Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients Are they two different diseases? Transplantation 79 2005 244 247
90. J. Trofe, J.F. Buell, T.M. Beebe Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients The Israel Penn International Transplant Tumor Registry experience Am J Transplant 5 2005 775 780
91. G. Opelz, B. Dohler Lymphomas after solid organ transplantation A collaborative transplant study report Am J Transplant 4 2004 222 230
92. P. Comoli, R. Maccario, F. Locatelli Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells Am J Transplant 5 2005 1415 1422
93. V.M. Brandenburg, D. Politt, M. Ketteler Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation Transplantation 77 2004 1566 1571
94. S. Durieux, L. Mercadal, P. Orcel Bone mineral density and fracture prevalence in long-term kidney graft recipients Transplantation 74 2002 496 500
95. J. Cunningham Posttransplantation bone disease Transplantation 79 2005 629 634
96. E.A. Cruz, J.R. Lugon, V. Jorgetti, S.A. Draibe, A.B. Carvalho Histologic evolution of bone disease 6 months after successful kidney transplantation Am J Kidney Dis 44 2004 747 756
97. K.C. Abbott, J. Koff, E.M. Bohen Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States Transplantation 79 2005 330 336
98. R.G. De Sevaux, A.J. Hoitsma, F.H. Corstens, J.F. Wetzels Treatment with vitamin D and calcium reduces bone loss after renal transplantation A randomized study J Am Soc Nephrol 13 2002 1608 1614
99. M.A. Josephson, L.P. Schumm, M.Y. Chiu, C. Marshall, J.R. Thistlethwaite, S.M. Sprague Calcium and calcitriol prophylaxis attenuates posttransplant bone loss Transplantation 78 2004 1233 1236
100. A.A. El-Husseini, A.E. El-Agroudy, M. El-Sayed, M.A. Sobh, M.A. Ghoneim A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents Am J Transplant 4 2004 2052 2057
101. 3 to prevent bone loss in renal-transplant patients receiving low doses of steroids Transplantation 79 2005 108 115
102. D.N. Cruz, H.M. Brickel, J.J. Wysolmerski Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate Am J Transplant 2 2002 62 67
103. Amgen Inc Sensipar Package Insert 2004 Amgen Inc Thousand Oaks, CA
104. E.C. van den Ham, J.P. Kooman, M.L. Christiaans, J.P. van Hooff The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients Transpl Int 16 2003 82 87
105. W. El Haggan, N. Barthe, B. Vendrely One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine Transplant Proc 34 2002 1817 1818
106. E. Goffin, J.P. Devogelaer, A. Lalaoui Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation Transpl Int 15 2002 73 80
107. U. Yakupoglu, E. Baranowska-Daca, D. Rosen, R. Barrios, W.N. Suki, L.D. Truong Post-transplant nephrotic syndrome A comprehensive clinicopathologic study Kidney Int 65 2004 2360 2370
108. D.M. Cibrik Management of posttransplant recurrent renal disease Graft 7 2005 107 115
109. P.T. D'Cunha, R. Parasuraman, K.K. Venkat Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation Am J Transplant 5 2005 351 355
110. J.A. Butler, P. Roderick, M. Mullee, J.C. Mason, R.C. Peveler Frequency and impact of nonadherence to immunosuppressants after renal transplantation A systematic review Transplantation 77 2004 769 776
111. H. Vlaminck, B. Maes, G. Evers Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients Am J Transplant 4 2004 1509 1513
112. M. Loghman-Adham Medication noncompliance in patients with chronic disease Issues in dialysis and renal transplantation Am J Manag Care 9 2003 155 171
113. L. Penkower, M.A. Dew, D. Ellis, S.M. Sereika, J.M. Kitutu, R. Shapiro Psychological distress and adherence to the medical regimen among adolescent renal transplant recipients Am J Transplant 3 2003 1418 1425
114. F.L. Weng, A.K. Israni, M.M. Joffe Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation J Am Soc Nephrol 16 2005 1839 1848
115. B. Siegal, S. Greenstein Compliance and noncompliance in kidney transplant patients Cues for transplant coordinators J Transpl Coord 9 1999 104 108
116. M.A. Chisholm, M.A. Josephson Nonadherence to posttransplant medication regimens Strategies for improvement Graft 7 2005 222 232